Alcoholic cardiomyopathy and cardiovascular events - an insight from the Liptov region

P Kycina1, J Murin

  • 1Liptov Hospital, Department of Internal Medicine, ICU, Liptovsky, Mikulas, Slovakia. peter.kycina@gmail.com

Insights

Heavy alcohol consumption did not significantly impact cardiovascular events or echocardiographic parameters in consumers over a 4-year period. No significant differences were found in heart function, biochemical markers, or major cardiovascular events between groups.

Area of Science:

  • Cardiology
  • Alcohol-related research
  • Clinical investigation

Background:

  • Heavy alcohol consumption is a known risk factor for cardiovascular disease.
  • Understanding the specific impact on cardiac structure and function is crucial for public health.
  • Previous studies show varied results on the direct effects of heavy drinking on the heart.

Purpose of the Study:

  • To investigate the association between heavy alcohol consumption (≥80g/day) and cardiovascular events.
  • To evaluate echocardiographic parameters in heavy alcohol consumers.
  • To compare cardiovascular outcomes in individuals with different daily alcohol intake levels over 4 years.

Main Methods:

  • 100 heavy alcohol consumers (≥80g/day) without pre-existing cardiovascular disease were recruited.
  • Participants were divided into two groups based on daily alcohol intake.
  • A 4-year follow-up included clinical evaluation, echocardiography, biochemical analysis, and monitoring for cardiovascular events and rhythm disorders.

Main Results:

  • No significant differences were observed in ejection fraction (EF) or left atrium diameter (LA) between groups.
  • Left ventricular end-diastolic diameter (LVEDD) showed a non-significant trend towards being larger in the higher intake group (p=0.09).
  • No significant differences were found in the incidence of diabetes mellitus, heart failure, atrial fibrillation, stroke, delirium, or myocardial infarction between the groups.

Conclusions:

  • Heavy alcohol consumption, even at doses ≥80g/day, did not lead to significant differences in echocardiographic parameters or cardiovascular events over 4 years.
  • The study suggests that within the studied heavy drinking population, cardiac function and event rates were comparable.
  • Further research may be needed to explore potential long-term or subtle effects not captured in this cohort.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...